drugset / Trial / NCT02593526

Diuretic/Cool Dialysate Trial

NCT02593526

RandomizedFactorialOpen-labelTreatment

Summary

The proposed pilot study challenges the current widespread paradigm of discontinuing loop diuretics when initiating chronic HD and/or maintaining the dialysate at a constant temperature of 37 °C for all patients.

Timeline

Start
2017-01
Primary completion
2022-05-27
Completion
2022-05-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Bumetanide Small molecule